Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer (Q35024744)

5 August 2017

1 reference

title

Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer (English)

1 reference

5 August 2017

1 reference

1

Rafael Rosell

1 reference

5 August 2017

2

Frank Fossella

1 reference

5 August 2017

Luka Milas

3

1 reference

5 August 2017

Spanish Lung Cancer Group

series ordinal

4

1 reference

5 August 2017

publication date

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

38 Suppl 4

1 reference

5 August 2017

page(s)

43-49

1 reference

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Predictive molecular markers in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Increased expression of mRNAs for microtubule disassembly molecules during nerve regeneration

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Translational oncogenomics: toward rational therapeutic decision-making

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

Structural requirements for ErbB2 transactivation

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

The epidermal growth factor receptor as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(02)00171-X

7 January 2021

10.1016/S0169-5002(02)00171-X

Identifiers

DOI

1 reference

5 August 2017

1 reference